New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Cablivi caplacizumab-yhdp Click here for more information |
Ablynx U.S. | A von Willebrand factor-directed antibody fragment for treatment of acquired thrombotic thrombocytopenic purpura (aTTP). |
|
Egaten triclabendazole Click here for more information |
Novartis | An oral anthelmintic for treatment of fascioliasis. |
|
Herceptin Hylecta trastuzumab/hyaluronidase-oysk Click here for more information |
Genentech | A subcutaneous injection formulation for HER2-overexpressing breast cancer. |
|
Jeuveau prabotulinumtoxin A-xvfs |
Evolus | A botulinum toxin product to improve the appearance of frown lines between the eyebrows. |
|
Ontruzant trastuzumab-dttb |
Merck | A biosimilar to Herceptin for breast cancer and gastric/gastroesophageal junction cancer. |
|
Spravato esketamine Click here for more information |
Janssen | An NMDA receptor antagonist nasal spray for treatment-resistant depression. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Adhansia XR methylphenidate Click here for more information |
Purdue Pharma | New extended-release formulation for ADHD. |
|
Gloperba colchicine Click here for more information |
Romeg Therapeutics | A new oral solution formulation for prevention of gout flares in adults. |
|
Lotemax SM loteprednol etabonate Click here for more information |
Bausch + Lomb | New 0.38% steroid ophthalmic gel formulation to improve absorption. For post-op inflammation/pain following ocular surgery. |
|
Tosymra sumatriptan Click here for more information |
Promius Pharma | New 10 mg nasal spray formulation for acute migraine. |
| Brand/Generic | Company | Description |
|---|